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2008–2009 ISSCR Initiatives: Facilitating
Communication and EducationIn early 2008, the ISSCR held its inaugural global forum. Core
strategies emerged for the ISSCR to strengthen and drive
forward the field of stem cell research and ultimately, in a respon-
sible and transparent manner, its applications: to provide a
strong, unified and proactive voice for stem cell research; to
provide leadership in creating realistic expectations for advances
in stem cell therapy; and to engage multidisciplinary and clinical
constituencies in initiatives. Here, we describe some of our
efforts of the last year and outline how we have moved toward
these ends.
In 2006, the ISSCR released its Guidelines for the Conduct of
Human Embryonic Stem Cell Research, and in December 2008,
Guidelines for the Clinical Translation of Stem Cells. Each set of
guidelines is a valuable resource for the field, and a platform for
ongoing initiatives. The former guidelines have provided an inter-
nationally applicable benchmark for a high standard of practice
in human embryonic stem cell research and continue to play a
role in policy development around the world. The ISSCRRegistry
of Human Embryonic Stem Cell Line Provenance grew out of
these guidelines, and has itself become particularly relevant
with the evolving political climate in the USA. The latter guide-
lines represent a large step in the ISSCR’s professional leader-
ship in the arena of clinical translation, with concurrent outreach
to patients.
In the face of a rapidly changing research landscape and
unprecedented media coverage, the ISSCR is providing a
strong and unified voice for stem cell research by leveraging
the expertise of its task forces, committees, and other working
groups. The public focus on the field has generated great
expectations and has, at the same time, provided opportunity
for the less scrupulous to take advantage of people’s suffering.
Recognizing the threat that unregulated and premature appli-
cation of stem cell research holds to the field, we want to be
able to react proactively and swiftly. The ISSCR is a major
international professional organization that represents the
community of stem cell scientists and, as such, is well posi-
tioned to coordinate such efforts in scientific communities
worldwide.
Underpinning this major effort is professional and public
communication and education. Providing an ongoing posi-
tive environment for research and generating realistic expec-
tation relies on the effective communication of scientific
advances.
ISSCR Guidelines for the Clinical Translation of Stem
Cells and Patient Handbook on Stem Cell Therapies
In December 2008, the ISSCR released its Guidelines for the
Clinical Translation of StemCells. These guidelines define a road-
map for medical researchers and doctors, outlining what needs
to be accomplished to move stem cells from promising research
to proven treatments for patients safely and effectively. The
guidelines call for rigorous standards in the development of258 Cell Stem Cell 5, 258–263, September 4, 2009 ª2009 ISSCRstem cell therapies, founded on core principles, which include
the following:
d Stringent preclinical evaluation and rigorous, independent
scientific and ethical oversight for clinical use
d A thorough informed consent process, based on clear
information highlighting that the intervention is unproven
and detailing the risks associated with new stem cell
therapies
d Transparency in operations and reporting
To provide guidance to the members of public who are look-
ing for treatments now and who face an increasingly difficult
job in establishing the legitimacy of an enterprise, the ISSCR
developed Appendix A, a Patient Handbook on Stem Cell Ther-
apies. This stand-alone educational guide was created for
patients considering stem cell treatments. The handbook
provides background on stem cells and introduces patients
to what sort of questions they should be asking about therapies
they are offered. The ISSCR has received very favorable feed-
back on this handbook to date as well as considerable media
coverage. Collaborations are underway to translate the hand-
book into additional languages for greater benefit to various
communities. The guidelines and the patient handbook are
available on the ISSCR Web site: http://www.isscr.org/
clinical_trans.
Concerns regarding the exploitation of patients internationally
were paramount in a concerted public communications cam-
paign employed to ensure broad international dissemination
of the guidelines and the accompanying handbook to both
professional and public audiences. The campaign, which
included a press release (issued jointly with ISSCR’s affiliated
journal Cell Stem Cell), an article in the ISSCR pages of Cell
Stem Cell (Hyun et al., 2008), a YouTube video, op-eds, and
interviews with the task force members around the world,
won a Gold award from the Hermes Creative Awards in the
category of Media Relations: Publicity Campaign. Results
included more than 160 articles and blog postings about the
guidelines in 17 countries. The ISSCR thanks the California
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ISSCR: Annual ReportInstitute of Regenerative Medicine (CIRM) for their support in
these efforts.
These undertakings are part of a greater commitment from the
ISSCR to disseminate the guidelines, support clinical translation,
and generate realistic expectations through the development of
educational tools for patients, their families, and physicians in
the face of increasing direct-to-consumer marketing of stem
cell therapies. Continuing the work of the task force, the ISSCR
convened a clinical translation committee in 2009 with two
core mandates: (1) to develop forums and resources that allow
those interested to focus basic research questions toward the
needs of clinical translation, and (2) to protect the public who
are looking to the field of stem cell research with great expec-
tation.
The work undertaken by the ISSCR Task Force on the Clinical
Translation of Stem Cells was made possible thanks to the
partial support of the EUROCORES Programme EuroSTELLS,
a European Science Foundation (ESF) initiative supported by
the European Commission, Sixth Framework Programme,
under contract No. ERAS-CT-2003-980409. Research funding
is provided by participating national organizations. EuroSTELLS
is managed by the European Medical Research Councils
(EMRC) at the ESF. The ISSCR also thanks the Alzheimer’s
Research Foundation, The Ellison Medical Foundation, and
the Juvenile Diabetes Research Foundation Beta Cell Replace-
ment Advisory Committee for their generous financial support of
the task force.
‘‘The ISSCR is a leader. It was the ﬁrst to
organize the stem cell community on a global
scale.to develop ethical guidelines harmo-
nized across national borders to facilitate
global research collaboration.to discuss
the ethical challenges speciﬁc to stem cell
clinical trials.to publish guidelines on
patient recruitment and trial management.
And it was the ﬁrst to develop an annual
meeting that brings together the ever-
growing population of researchers around
theworld, alongwith leading funders, patient
advocacy groups, policy leaders, and human-
ists. In just a few short years, the ISSCR has
come to embody all the best attributes of
the stem cell world.’’
—R. Alta Charo, JD, Professor, University
of Wisconsin Law School, Madison, WI, USA
The ISSCR Registry of Human Embryonic Stem Cell Line
Provenance
Extending the work of the ISSCR Guidelines for the Conduct of
Human Embryonic Stem Cell Research, the ISSCR moved
forward to create a Registry of Human Embryonic Stem Cell
Line Provenance. The registry has been designed to receive
and collate information and documentation pertaining to the
derivation of human embryonic stem cell lines, the oversight
processes in place at the time, and other ethically relevant
parameters. The purpose of the ISSCR registry is to provide
common access to such data in the manner local stem cellresearch oversight bodies or funding bodies would customarily
accept, thereby minimizing the burden on investigators, over-
sight bodies, and sharing institutions and facilitating a broad
assimilation of lines from around the world by the research
community.
The registry includes a mechanism to work specifically with
individual jurisdictions or funding agencies in the registration
and evaluation of lines for the registry, with the objective of listing
lines that are eligible for particular regulatory or funding systems.
The ISSCR is pursuing collaborations to maximize the value of
the registry to various individuals, institutions, and funding
groups.
Access to the platform for data submission is expected to
open publically over the next fewmonths, with continued expan-
sion of the registered listings as the registry develops.
Advocacy for All Forms of Stem Cell Research
To ensure that researchers are equipped to use all their expe-
rience and innovation in probing the basic biomedical principles
that underlie medical research and treatment, the ISSCR advo-
cates for all forms of stem cell research performed under
rigorous ethical standards. The past year has seen a number
of landmarks, notably the changing political administration in
the USA, where it has been important for the ISSCR to reiterate
this position firmly. In advance of the U.S. elections, the ISSCR
joined other leading scientists to issue an open letter urging
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ISSCR: Annual Reportsupport for all types of stem cell research and asserting that
research priorities and funding should be based on sound
scientific judgment. More than 750 signatories from around
the world joined us. In response to the NIH draft Guidelines
for Human Stem Cell Reseach, the ISSCR, with an eye to the
wide variety of policy around the world, again asserted the
importance of a funding policy influenced by scientific merit
and rigorous ethical standards. The ISSCR urged the NIH to
open discussions on funding research carried out with human
pluripotent stem cell lines derived from sources other than
excess reproductive in vitro fertilization embryos.
Professional Communication—Strong Partners
Cell Stem Cell
June 2009 marked the second anniversary of ISSCR’s official
affiliated journal, Cell Stem Cell. Winning a ‘‘Best New Journal
in Science Technology and Medicine’’ award in its first year,
the journal made a strong start and has maintained this trend.
This year, Cell Stem Cell was assigned an inaugural impact
factor—a measure of the frequency with which the average
article in the journal is cited in a given year—of 16.826 (Thomson
Reuters JCR). This exceptional preliminary figure clearly indi-
cates the influence that Cell Stem Cell has rapidly built for itself
in the field.
Cell Stem Cell includes dedicated pages for ISSCR-communi-
catedarticles ineach issue,avehicle for the ISSCRtocommunicate
society news and undertakings and to raise issues for discussion
within the research community. ISSCR members are offered
a heavily discounted subscription rate to the journal.
Current Protocols in Stem Cell Biology
The ISSCR continues its association with the reference journal,
Current Protocols in Stem Cell Biology, which offers detailed
protocols in the developing field of stem cell biology. Current
Protocols in Stem Cell Biology adds new methods and ideas
as the field expands and now offers 70 modules. In 2008, the
journal was indexed in the MEDLINE/PubMed database.
Personal subscriptions to this valuable resource are available
at a discounted rate to ISSCR members.
Affiliated Meetings
To interface with regional, multidisciplinary, and clinical constit-
uencies, the ISSCR has connected with a number of groups to
support the development of a variety of events.
Translation of Stem Cell Therapies Symposium
The ISSCR worked with the International Society for Cellular
Therapy (ISCT) to offer a forum exploring the critical issues and
challenges facing the development of stem cell therapies, from
early-stage to late-stage translation. A 1 day workshop was
held in association with the ISCT 5th Annual Meeting, May 2,
2009, San Diego, CA, USA.
‘‘The ISSCR provides the latest and cutting
edge scientiﬁc ﬁndings.and serves as
a world opinion leader in stem cell research,
application, and policy.’’
—Shinya Yamanaka, MD, PhD, Professor,
Kyoto University, Kyoto, Japan and Senior
Investigator, Gladstone Institute of Cardio-
vascular Disease, San Francisco, CA, USA260 Cell Stem Cell 5, 258–263, September 4, 2009 ª2009 ISSCRScreening Stem Cells: From Reprogramming
to Regenerative Medicine
The ISSCR with the Harvard Stem Cell Institute sponsored a
satellite symposium of the Society for Biomolecular Sciences
on September 2–3, 2009, in Boston, MA, USA. The 2 day sympo-
sium aligned current themes in high-throughput screening
technologies with stem cell biology, bringing together a unique
mix of industry and academic leaders.
International Symposium on Stem Cell Research
On November 12–14, 2009, in Buenos Aires, Argentina, a range
of international and local speakers will present their recent find-
ings in stem cell research with a focus on cardiologic and
neurological diseases. Organized by the Ministry of Science,
Technology and Productive Innovation of Argentina, in conjunc-
tion with the ISSCR, this meeting is an excellent opportunity to
showcase local research and development in the stem cell
arena.
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ISSCR: Annual ReportSBE’s Second International Conference on Stem Cell
Engineering
The ISSCR is cosponsoring the Society for Biological Engi-
neering (SBE)’s second stem-cell-focused conference on May
2–5, 2010, in Boston, MA, USA. The conference will bring
together the bioengineering and stem cell biology communities,
emphasizing how basic and applied efforts in stem cell biology
and engineering can combine to aid in the development of
stem cell therapeutics and bioprocesses.
The 2009 ISSCR Public Symposium
Each year in conjunction with the ISSCR Annual Meeting, the
Public Education Committee develops an educational program
tailored to the local community. Around 250 people attended
the 2009 ISSCR Public Symposium, ‘‘Everything You Always
Wanted to Know About Stem Cells But Were Afraid to Ask,’’
held in collaboration with the la Caixa Foundation at Barcelona’s
renowned CosmoCaixa science museum. This year’s program
was a multimedia exploration of stem cell research supported
by ESTOOLS, EuroStemCell, EuroSyStem, OptiStem, and
NeuroStemcell. The program began with a 15 minute movie,
Stem Cell Story, in English with Spanish subtitles and a film
clip introducing induced pluripotent stem cells (iPSCs), both
from EuroStemCell and EuroSyStem. The symposium con-
cluded with a lively panel discussion with filmmakers and
experts in stem cell research and ethics from Spain, the UK,
and the USA, with Catalan/English translation. In conjunction
with the evening event, the museum hosted a thought-provoking
photo exhibition, ‘‘Smile of a Stem Cell,’’ from ESTOOLS.
The program was developed under the guidance of Tariq
Enver and Pamela Hines from the ISSCR Public Education
Committee, with the support of Esther Baena, Olaia Naveiras,
Clare Blackburn and Emma Kemp (EuroStemCell), and Sebas-
tien Duprat (ESTOOLS). The ISSCR thanks la Caixa Foundation
for their assistance and collaboration in developing this truly
unique event.
Donors
The ISSCR provides a unique donation opportunity for those
seeking to help ensure the free flow of vital information of stem
cell research and strengthen the cooperation that is fundamental
to effective international research. Donations aid not only the
ISSCR’s community of scientists in disseminating scientific
data, but also help fund junior investigator and internationaltravel awards and general operating expenses. The ISSCR
thanks its 2008 donors for enabling ISSCR to continue to move
forward on its path to support major scientific achievements
worldwide.
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